Skip to main content
Top
Published in: Abdominal Radiology 1/2024

15-10-2023 | Rectal Cancer | Hollow Organ GI

T1 mapping in evaluation of clinicopathologic factors for rectal adenocarcinoma

Authors: Juan Li, Peisi Kou, Liangjie Lin, Yunfei Xiao, Hongrui Jin, Yong Zhang, Jingliang Cheng

Published in: Abdominal Radiology | Issue 1/2024

Login to get access

Abstract

Objective

T1 mapping has been increasingly applied in the study of tumor. The purpose of this study was to evaluate the value of T1 mapping in evaluating clinicopathologic factors for rectal adenocarcinoma.

Materials and methods

Eighty-six patients with rectal adenocarcinoma confirmed by surgical pathology who underwent preoperative pelvic MRI were retrospectively analyzed. High-resolution T2-weighted imaging (T2WI), T1 mapping, and diffusion-weighted imaging (DWI) were performed. T1 and apparent diffusion coefficient (ADC) parameters were compared among different associated tumor markers, tumor grades, stages, and structure invasion statuses. A receiver operating characteristic (ROC) analysis was estimated.

Results

T1 value showed significant difference between high- and low-grade tumors ([1531.5 ± 84.7 ms] vs. [1437.1 ± 80.3 ms], < 0.001). T1 value was significant higher in positive than in negative perineural invasion ([1495.7 ± 89.2 ms] vs. [1449.4 ± 88.8 ms], < 0.05). No significant difference of T1 or ADC was observed in different CEA, CA199, T stage, N stage, lymphovascular invasions, extramural vascular invasion (EMVI), and circumferential resection margin (CRM) (> 0.05). The AUC under ROC curve of T1 value were 0.796 in distinguishing high- from low-grade rectal adenocarcinoma. The AUC of T1 value in distinguishing perineural invasion was 0.637.

Conclusion

T1 value was helpful in assessing pathologic grade and perineural invasion correlated with rectal cancer.

Graphical abstract

Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249.CrossRefPubMed Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249.CrossRefPubMed
2.
go back to reference Wong MCS, Huang J, Lok V, Wang J, Fung F, Ding H, et al. Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location. Clin Gastroenterol Hepatol. 2021;19(5):955-966.e61.CrossRefPubMed Wong MCS, Huang J, Lok V, Wang J, Fung F, Ding H, et al. Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location. Clin Gastroenterol Hepatol. 2021;19(5):955-966.e61.CrossRefPubMed
3.
go back to reference Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018; 29:263.CrossRef Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018; 29:263.CrossRef
5.
go back to reference Nougaret S, Jhaveri K, Kassam Z, Lall C, Kim DH. Rectal cancer MR staging: pearls and pitfalls at baseline examination. Abdom Radiol (NY). 2019;44(11):3536-3548.CrossRefPubMed Nougaret S, Jhaveri K, Kassam Z, Lall C, Kim DH. Rectal cancer MR staging: pearls and pitfalls at baseline examination. Abdom Radiol (NY). 2019;44(11):3536-3548.CrossRefPubMed
6.
go back to reference Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ. MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management. Radiographics. 2019;39(2):367-387. Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ. MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management. Radiographics. 2019;39(2):367-387.
7.
go back to reference Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol. 2019;92(1096):20180655.CrossRefPubMedPubMedCentral Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol. 2019;92(1096):20180655.CrossRefPubMedPubMedCentral
8.
go back to reference Zhu L, Pan Z, Ma Q, Yang W, Shi H, Fu C, et al. Diffusion kurtosis imaging study of rectal adenocarcinoma associated with histopathologic prognostic factors: preliminary findings. Radiology. 2017;284(1):66-76.CrossRefPubMed Zhu L, Pan Z, Ma Q, Yang W, Shi H, Fu C, et al. Diffusion kurtosis imaging study of rectal adenocarcinoma associated with histopathologic prognostic factors: preliminary findings. Radiology. 2017;284(1):66-76.CrossRefPubMed
9.
go back to reference Yamada I, Yoshino N, Hikishima K, Miyasaka N, Yamauchi S, Uetake H, et al. Colorectal carcinoma: Ex vivo evaluation using 3-T high-spatial-resolution quantitative T2 mapping and its correlation with histopathologic findings. Magn Reson Imaging. 2017; 38:174-181.CrossRefPubMed Yamada I, Yoshino N, Hikishima K, Miyasaka N, Yamauchi S, Uetake H, et al. Colorectal carcinoma: Ex vivo evaluation using 3-T high-spatial-resolution quantitative T2 mapping and its correlation with histopathologic findings. Magn Reson Imaging. 2017; 38:174-181.CrossRefPubMed
10.
go back to reference Ma L, Lian S, Liu H, Meng T, Zeng W, Zhong R, et al. Diagnostic performance of synthetic magnetic resonance imaging in the prognostic evaluation of rectal cancer. Quant Imaging Med Surg. 2022;12(7):3580-3591.CrossRefPubMedPubMedCentral Ma L, Lian S, Liu H, Meng T, Zeng W, Zhong R, et al. Diagnostic performance of synthetic magnetic resonance imaging in the prognostic evaluation of rectal cancer. Quant Imaging Med Surg. 2022;12(7):3580-3591.CrossRefPubMedPubMedCentral
11.
go back to reference Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M. T1 Mapping: Basic Techniques and Clinical Applications. JACC Cardiovasc Imaging. 2016;9(1):67-81.CrossRefPubMed Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M. T1 Mapping: Basic Techniques and Clinical Applications. JACC Cardiovasc Imaging. 2016;9(1):67-81.CrossRefPubMed
12.
go back to reference Gao Y, Wang HP, Liu MX, Liu MX, Gu H, Yuan XS, et al. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis. Eur Radiol. 2022;33:1982-1991.CrossRefPubMed Gao Y, Wang HP, Liu MX, Liu MX, Gu H, Yuan XS, et al. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis. Eur Radiol. 2022;33:1982-1991.CrossRefPubMed
13.
go back to reference Liu M, Shao L, Yang Z, Wang Q, Wu B, Liu X, et al. Extracellular Volume Fraction Based on Cardiac Magnetic Resonance T1 Mapping: An Effective Way to Evaluate Cardiac Injury Caused by Cardiac Amyloidosis in Patients with Multiple Myeloma. J Immunol Res. 2022; 2022:3094933.CrossRefPubMedPubMedCentral Liu M, Shao L, Yang Z, Wang Q, Wu B, Liu X, et al. Extracellular Volume Fraction Based on Cardiac Magnetic Resonance T1 Mapping: An Effective Way to Evaluate Cardiac Injury Caused by Cardiac Amyloidosis in Patients with Multiple Myeloma. J Immunol Res. 2022; 2022:3094933.CrossRefPubMedPubMedCentral
14.
go back to reference Wu J, Shi Z, Zhang Y, Yan J, Shang F, Wang Y, et al. Native T1 Mapping in Assessing Kidney Fibrosis for Patients with Chronic Glomerulonephritis. Front Med (Lausanne). 2021; 8:772326.CrossRefPubMedPubMedCentral Wu J, Shi Z, Zhang Y, Yan J, Shang F, Wang Y, et al. Native T1 Mapping in Assessing Kidney Fibrosis for Patients with Chronic Glomerulonephritis. Front Med (Lausanne). 2021; 8:772326.CrossRefPubMedPubMedCentral
15.
go back to reference Von Ulmenstein S, Bogdanovic S, Honcharova-Biletska H, Blümel S, Deibel AR, Segna D, et al. Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard. Abdom Radiol (NY). 2022;47(11):3746-3757.CrossRef Von Ulmenstein S, Bogdanovic S, Honcharova-Biletska H, Blümel S, Deibel AR, Segna D, et al. Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard. Abdom Radiol (NY). 2022;47(11):3746-3757.CrossRef
16.
go back to reference Li J, Cao B, Bi X, Chen W, Wang L, Du Z, et al. Evaluation of liver function in patients with chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 mapping at different acquisition time points: a feasibility study. Radiol Med. 2021; 126(9):1149-1158.CrossRefPubMed Li J, Cao B, Bi X, Chen W, Wang L, Du Z, et al. Evaluation of liver function in patients with chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 mapping at different acquisition time points: a feasibility study. Radiol Med. 2021; 126(9):1149-1158.CrossRefPubMed
17.
go back to reference Liu Z, Yang S, Chen X, Luo C, Feng J, Chen H, et al. Nomogram development and validation to predict Ki-67 expression of hepatocellular carcinoma derived from Gd-EOB-DTPA-enhanced MRI combined with T1 mapping. Front Oncol. 2022; 12:954445.CrossRefPubMedPubMedCentral Liu Z, Yang S, Chen X, Luo C, Feng J, Chen H, et al. Nomogram development and validation to predict Ki-67 expression of hepatocellular carcinoma derived from Gd-EOB-DTPA-enhanced MRI combined with T1 mapping. Front Oncol. 2022; 12:954445.CrossRefPubMedPubMedCentral
18.
go back to reference Wang S, Li J, Zhu D, Hua T, Zhao B. Contrast-enhanced magnetic resonance (MR) T1 mapping with low-dose gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) is promising in identifying clear cell renal cell carcinoma histopathological grade and differentiating fat-poor angiomyolipoma. Quant Imaging Med Surg. 2020;10(5):988-998.CrossRefPubMedPubMedCentral Wang S, Li J, Zhu D, Hua T, Zhao B. Contrast-enhanced magnetic resonance (MR) T1 mapping with low-dose gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) is promising in identifying clear cell renal cell carcinoma histopathological grade and differentiating fat-poor angiomyolipoma. Quant Imaging Med Surg. 2020;10(5):988-998.CrossRefPubMedPubMedCentral
19.
go back to reference Li J, Gao X, Dominik Nickel M, Cheng J, Zhu J. Native T1 mapping for differentiating the histopathologic type, grade, and stage of rectal adenocarcinoma: a pilot study. Cancer Imaging. 2022;22(1):30.CrossRefPubMedPubMedCentral Li J, Gao X, Dominik Nickel M, Cheng J, Zhu J. Native T1 mapping for differentiating the histopathologic type, grade, and stage of rectal adenocarcinoma: a pilot study. Cancer Imaging. 2022;22(1):30.CrossRefPubMedPubMedCentral
20.
go back to reference Gilligan LA, Dillman JR, Tkach JA, Xanthakos SA, Gill JK, Trout AT. Magnetic resonance imaging T1 relaxation times for the liver, pancreas and spleen in healthy children at 1.5 and 3 tesla. Pediatric Radiology. 2019;49(8):1018-1024.CrossRefPubMed Gilligan LA, Dillman JR, Tkach JA, Xanthakos SA, Gill JK, Trout AT. Magnetic resonance imaging T1 relaxation times for the liver, pancreas and spleen in healthy children at 1.5 and 3 tesla. Pediatric Radiology. 2019;49(8):1018-1024.CrossRefPubMed
21.
go back to reference Inoue A, Sheedy SP, Heiken JP, Mohammadinejad P, Graham RP, Lee HE, et al. MRI-detected extramural venous invasion of rectal cancer: Multimodality performance and implications at baseline imaging and after neoadjuvant therapy. Insights Imaging. 2021;12(1):110.CrossRefPubMedPubMedCentral Inoue A, Sheedy SP, Heiken JP, Mohammadinejad P, Graham RP, Lee HE, et al. MRI-detected extramural venous invasion of rectal cancer: Multimodality performance and implications at baseline imaging and after neoadjuvant therapy. Insights Imaging. 2021;12(1):110.CrossRefPubMedPubMedCentral
22.
go back to reference Zhang XY, Wang S, Li XT, Wang YP, Shi YJ, Wang L, et al. MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival. Radiology. 2018;289(3):677-685.CrossRefPubMed Zhang XY, Wang S, Li XT, Wang YP, Shi YJ, Wang L, et al. MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival. Radiology. 2018;289(3):677-685.CrossRefPubMed
23.
go back to reference Meng T, He N, He H, Liu K, Ke L, Liu H, et al. The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI. Cancer Imaging. 2020;20(1):88.CrossRefPubMedPubMedCentral Meng T, He N, He H, Liu K, Ke L, Liu H, et al. The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI. Cancer Imaging. 2020;20(1):88.CrossRefPubMedPubMedCentral
24.
go back to reference Adams LC, Jurmeister P, Ralla B, Bressem KK, Fahlenkamp UL, Engel G, et al. Assessment of the extracellular volume fraction for the grading of clear cell renal cell carcinoma: first results and histopathological findings. Eur Radiol. 2019;29(11):5832-5843CrossRefPubMed Adams LC, Jurmeister P, Ralla B, Bressem KK, Fahlenkamp UL, Engel G, et al. Assessment of the extracellular volume fraction for the grading of clear cell renal cell carcinoma: first results and histopathological findings. Eur Radiol. 2019;29(11):5832-5843CrossRefPubMed
25.
go back to reference Qin X, Yang T, Huang Z, Long L, Zhou Z, Li W, et al. Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. Oncol Lett. 2019;18(3):2322-2329.PubMedPubMedCentral Qin X, Yang T, Huang Z, Long L, Zhou Z, Li W, et al. Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. Oncol Lett. 2019;18(3):2322-2329.PubMedPubMedCentral
26.
go back to reference Li J, Lin L, Gao X, Li S, Cheng J. Amide Proton Transfer Weighted and Intravoxel Incoherent Motion Imaging in Evaluation of Prognostic Factors for Rectal Adenocarcinoma. Front Oncol. 2022; 11:783544.CrossRefPubMedPubMedCentral Li J, Lin L, Gao X, Li S, Cheng J. Amide Proton Transfer Weighted and Intravoxel Incoherent Motion Imaging in Evaluation of Prognostic Factors for Rectal Adenocarcinoma. Front Oncol. 2022; 11:783544.CrossRefPubMedPubMedCentral
27.
go back to reference Yuan Y, Pu H, Chen GW, Chen XL, Liu YS, Liu H, et al. Diffusion-weighted MR volume and apparent diffusion coefficient for discriminating lymph node metastases and good response after chemoradiation therapy in locally advanced rectal cancer. Eur Radiol. 2021;31(1):200-211.CrossRefPubMed Yuan Y, Pu H, Chen GW, Chen XL, Liu YS, Liu H, et al. Diffusion-weighted MR volume and apparent diffusion coefficient for discriminating lymph node metastases and good response after chemoradiation therapy in locally advanced rectal cancer. Eur Radiol. 2021;31(1):200-211.CrossRefPubMed
28.
go back to reference Ge YX, Hu SD, Wang Z, Guan RP, Zhou XY, Gao QZ, et al. Feasibility and reproducibility of T2 mapping and DWI for identifying malignant lymph nodes in rectal cancer. Eur Radiol. 2021;31(5):3347-3354.CrossRefPubMed Ge YX, Hu SD, Wang Z, Guan RP, Zhou XY, Gao QZ, et al. Feasibility and reproducibility of T2 mapping and DWI for identifying malignant lymph nodes in rectal cancer. Eur Radiol. 2021;31(5):3347-3354.CrossRefPubMed
29.
go back to reference Mc Entee PD, Shokuhi P, Rogers AC, Mehigan BJ, McCormick PH, Gillham CM, et al. Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death. Eur J Surg Oncol. 2022;48(7):1638-1642.CrossRefPubMed Mc Entee PD, Shokuhi P, Rogers AC, Mehigan BJ, McCormick PH, Gillham CM, et al. Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death. Eur J Surg Oncol. 2022;48(7):1638-1642.CrossRefPubMed
Metadata
Title
T1 mapping in evaluation of clinicopathologic factors for rectal adenocarcinoma
Authors
Juan Li
Peisi Kou
Liangjie Lin
Yunfei Xiao
Hongrui Jin
Yong Zhang
Jingliang Cheng
Publication date
15-10-2023
Publisher
Springer US
Published in
Abdominal Radiology / Issue 1/2024
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-023-04045-2

Other articles of this Issue 1/2024

Abdominal Radiology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine